Marwa Tarek ElRakaiby

Dr. Marwa Tarek ElRakaiby

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in OMICS: A Journal of Integrative Biology
Verified
Journal Article
Closed access
MEMarwa Tarek ElRakaiby
Marwa Tarek ElRakaiby
BDBas E. Dutilh
Bas E. Dutilh
MRMariam R. Rizkallah
Mariam R. Rizkallah
ABAnnemarie Boleij
Annemarie Boleij
JCJason N. Cole
Jason N. Cole
Ramy AzizRamy Aziz
Ramy Aziz
The Human Microbiome Project (HMP) is a global initiative undertaken to identify and characterize the collection of human-associated microorganisms at multiple anatomic sites (skin, mouth, nose, colon, vagina), and to determine how intra-individual and inter-individual alterations in the microbiome influence human health, immunity, and different disease states. In this review article, we summarize the key findings and applications of the HMP that may impact pharmacology and personalized therapeutics. We propose a microbiome cloud model , reflecting the temporal and spatial uncertainty of defining an individual's microbiome composition, with examples of how intra-individual variations (such as age and mode of delivery) shape the microbiome structure. Additionally, we discuss how this microbiome cloud concept explains the difficulty to define a core human microbiome and to classify individuals according to their biome types. Detailed examples are presented on microbiome changes related to colorectal cancer, antibiotic administration, and pharmacomicrobiomics, or drug–microbiome interactions, highlighting how an improved understanding of the human microbiome, and alterations thereof, may lead to the development of novel therapeutic agents, the modification of antibiotic policies and implementation, and improved health outcomes. Finally, the prospects of a collaborative computational microbiome research initiative in Africa are discussed.

19 September 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
Farah M. AbdelhamedFarah M. Abdelhamed
Farah M. Abdelhamed
Nourtan F. AbdeltawabNourtan F. Abdeltawab
Nourtan F. Abdeltawab
MEMarwa Tarek ElRakaiby
Marwa Tarek ElRakaiby
Rehab ShammaRehab Shamma
Rehab Shamma
NMNayera A. Moneib
Nayera A. Moneib
Antibiotics are frequently used in acne treatment and their prolonged use has led to an emergence of resistance. This study aimed to investigate the use of natural antimicrobials as an alternative therapy. The antimicrobial and anti-inflammatory activities of five commonly used essential oils (EOs) (tea tree, clove, thyme, mentha and basil EOs), and their possible mechanisms of action against Cutibacterium acnes and Staphylococcus epidermidis, were explored. The effect of the most potent EO on membrane permeability was elucidated and its anti-inflammatory action, when formulated as nanoemulsion, was tested in an in vivo acne model. The in vitro studies showed that thyme EO had the most potent antimicrobial and antibiofilm activity, with phenolics and terpenoids as main antimicrobial constituents of EO. Thyme EO affected cell membrane permeability of both bacterial species, evident by the detection of the leakage of intracellular ions and membrane integrity by the leakage of nucleic acids. Morphological alteration in bacterial cells was confirmed by transmission electron microscopy. Thyme EO nanoemulsion led to the suppression of an inflammatory response in acne animal models along with a bacterial load decrease and positive histopathological changes. Collectively, thyme EO nanoemulsion showed potent antimicrobial and anti-inflammatory effects compared to the reference antibiotics, suggesting its effectiveness as a natural alternative in acne treatment.

3 October 2018 in Expert Opinion on Drug Metabolism & Toxicology
Verified
Journal Article
Closed access
Ramy AzizRamy Aziz
Ramy Aziz
SHShaimaa M. Hegazy
Shaimaa M. Hegazy
RYReem Yasser
Reem Yasser
MRMariam R. Rizkallah
Mariam R. Rizkallah
MEMarwa Tarek ElRakaiby
Marwa Tarek ElRakaiby
Introduction: Pharmacomicrobiomics and toxicomicrobiomics study how variations within the human microbiome (the combination of human-associated microbial communities and their genomes) affect drug disposition, action, and toxicity. These emerging fields, interconnecting microbiology, bioinformatics, systems pharmacology, and toxicology, complement pharmacogenomics and toxicogenomics, expanding the scope of precision medicine. Areas covered: This article reviews some of the most recently reported pharmacomicrobiomic and toxicomicrobiomic interactions. Examples include the impact of the human gut microbiota on cardiovascular drugs, natural products, and chemotherapeutic agents, including immune checkpoint inhibitors. Although the gut microbiota has been the most extensively studied, some key drug-microbiome interactions involve vaginal, intratumoral, and environmental bacteria, and are briefly discussed here. Additionally, computational resources, moving the field from cataloging to predicting interactions, are introduced. Expert opinion: The rapid pace of discovery triggered by the Human Microbiome Project is moving pharmacomicrobiomic research from scattered observations to systematic studies focusing on screening microbiome variants against different drug classes. Better representation of all human populations will improve such studies by avoiding sampling bias, and the integration of multiomic studies with designed experiments will allow establishing causation. In the near future, pharmacomicrobiomic testing is expected to be a key step in screening novel drugs and designing precision therapeutics.

8 January 2013 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
TETamer Essam
Tamer Essam
MEMarwa Tarek ElRakaiby
Marwa Tarek ElRakaiby
AHAbdelgawad Hashem
Abdelgawad Hashem

1 August 2018 in Journal of Chromatography B
Verified
Journal Article
Closed access
MAMedhat A. Al-Ghobashy
Medhat A. Al-Ghobashy
SKSamah M. Kamal
Samah M. Kamal
GEGhada M. El-Sayed
Ghada M. El-Sayed
AAAli K. Attia
Ali K. Attia
MNMohamed Nagy
Mohamed Nagy
RARamy K. Aziz
Ramy K. Aziz

1 August 2018 in OMICS: A Journal of Integrative Biology
Verified
Journal Article
Closed access
WEWalaa A. Eraqi
Walaa A. Eraqi
MEMarwa Tarek ElRakaiby
Marwa Tarek ElRakaiby
SMSalwa A. Megahed
Salwa A. Megahed
NYNoha H. Yousef
Noha H. Yousef
MEMostafa S. Elshahed
Mostafa S. Elshahed
AYAymen S. Yassin
Aymen S. Yassin
World freshwater supplies are in need of microbiome diversity analyses as a first step to future ecological studies, and to monitor water safety and quality. The Nile is a major north-flowing river in Africa that displays both spatial and temporal variations in its water quality. Here, we present the first microbiome analysis of the Nile River water in two seasons: (1) summer representing the wet season, and (2) winter representing the dry season, as sampled around Cairo, the capital of Egypt. Surface river water samples were collected from selected locations along the path of river, and the microbial composition was analyzed by next-generation sequencing of the 16S rRNA gene. We found a striking stability in the Nile microbiome community structure along the examined geographical urban sites and between the wet and dry seasons as evidenced by the high proportion of shared operational taxonomic unit values among all samples. The community was dominated by the Cyanobacteria (mainly Synechococcus ), Actinobacteria candidate family (ACK-M1), and Proteobacteria (mainly family Comamonadaceae ). Among these dominant taxa, Synechococcus exhibited seasonal driven variation in relative abundance. Other taxa were predominantly rare across all seasons and locations, including genera members of which have been implicated as pathogens such as Acinetobacter , Aeromonas , and Legionella . In addition, comparisons with data on freshwater microbiome in other world regions suggest that surface water communities in large rivers exhibit limited variation. Our results offer the first insights on microbial composition in one of the most notable rivers near a large metropolis.